CNAT - Conatus Pharmaceuticals EPS beats by $0.02 misses on revenue November, 05 2019 04:55 PM Conatus Pharmaceuticals Conatus Pharmaceuticals (NASDAQ:CNAT): Q3 GAAP EPS of -$0.10 beats by $0.02.More news on: Conatus Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...